TY  - CONF

T1  - The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response - exploratory evidence for direct anti-tumor activity in breast cancer.

JO  - CANCER RESEARCH

PY  - 2009/01/15

AU  - Winter MC

AU  - Thorpe HC

AU  - Burkinshaw R

AU  - Beevers SJ

AU  - Coleman RE

ED  - 

VL  - 69

IS  - 2

SP  - 330S

EP  - 330S

Y2  - 2025/10/10

ER  -